Evaluation of the Impact of Pulsed Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation

Who May Qualify: - Symptomatic Paroxysmal Atrial Fibrillation (AF) that terminates spontaneously or with intervention within 7 days of onset - Age range: 18-70 years - Willing and capable of providing willing to sign a consent form - Able and willing to comply with all pre-, post-, and follow-up testing and requirements Who Should NOT Join This Trial: - Previously diagnosed Persistent AF (\> 7 days in duration) - Previous LA ablation - Previous cardiac surgery - Myocardial Infarction within the previous 3 months - Severely compromised Left Ventricular Ejection Fraction (LVEF\<40%) - Presence of implanted pacemaker or Implantable Cardioverter-Defibrillator (ICD) or other implanted metal cardiac device that may interfere with the pulsed electric field energy - Acute illness, active systemic infection, or sepsis - Presence of intracardiac thrombus, myxoma, tumor, interatrial baffle or patch or other abnormality that precludes catheter introduction or manipulation. - Severe mitral regurgitation - Woman who are pregnant, lactating, or who are planning to become pregnant during the course of the clinical investigation Always talk to your doctor about whether this trial is right for you.